FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort study

To evaluate arterial fluorodeoxyglucose (FDG) uptake as a marker of arterial inflammation in multiple vascular beds in patients treated with anthracycline-based chemotherapy for Hodgkin lymphoma (HL). We used maximum standardized uptake value (SUVmax) and target-to-background ratio (TBR) to quantify...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawal, Ismaheel O., Orunmuyi, Akintunde T., Popoola, Gbenga O., Lengana, Thabo, Mokoala, Kgomotso M.G., Ankrah, Alfred O., Sathekge, Mike M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710260/
https://www.ncbi.nlm.nih.gov/pubmed/33235083
http://dx.doi.org/10.1097/MD.0000000000023259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710260/
https://www.ncbi.nlm.nih.gov/pubmed/33235083
http://dx.doi.org/10.1097/MD.0000000000023259

Ejemplares similares